Indivior Pharmaceuticals Inc
NASDAQ: INDV0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Joseph J. Ciaffoni
- Employees
- 1,030
- Headquarters
- North Chesterfield, United States
- IPO year
- 2014
- Market cap
- $4.8B
- Website
- https://www.indivior.com
Loading INDV…
Loading profile data…Frequently asked questions about INDV
What does Indivior Pharmaceuticals Inc (INDV) do?
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its bus...
Where does INDV trade?
Indivior Pharmaceuticals Inc (INDV) trades on the NASDAQ Global Select.
What sector is INDV in?
Indivior Pharmaceuticals Inc (INDV) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Indivior Pharmaceuticals Inc?
Joseph J. Ciaffoni is the chief executive officer of Indivior Pharmaceuticals Inc (INDV).
Where is Indivior Pharmaceuticals Inc headquartered?
Indivior Pharmaceuticals Inc is headquartered in United States.
Does INDV pay a dividend?
Indivior Pharmaceuticals Inc (INDV) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did INDV go public?
Indivior Pharmaceuticals Inc (INDV) completed its initial public offering in 2014.